New publication: Rethinking intercurrent events in defining estimands for tuberculosis trials — joint work with colleagues at @MRCCTU @LSHTM @UCSF . @Brennan_Kahan @PPJPhillips @IanWhit25399993 .

RT @stats_q: Want to design a late phase trial to optimise some aspects of tretament administration like duration or frequency? Interested….

RT @sophiemerrick1: Interested in learning more about survival analysis in clinical trials? Join our next @NIHRresearch learning lecture wi….

RT @BabakOskooei: A new short course:.Sample size calculations in randomised clinical trials: Beyond the basics. See the link for more i….

RT @LSHTM_datastats: Join us for inaugural lectures from Jonathan Bartlett, Ruth Keogh and Fizz Williamson. "Please mind the methodology ga….

RT @TheStatsGeek: Very happy that 2nd edition of Multiple Imputation and its Application is now available https://t….

RT @stats_q: New paper just out: we tend to always use the Hazard Ratio as population-level summary measure in clinical trials with surviva….

RT @MRCCTU: If you are at the #SCT2023 annual conference @SCTorg don’t miss the latest work from our methodologists @MaxParmarMRCUCL @matts….

RT @MRCCTU: Join us to celebrate the launch of our Capacity Strengthening Hub on @info_tghn!. Prof Sarah Walker will explore how new #Clini….

RT @UCL_CCTU: If you're considering our online MSc Statistics for Clinical Trials have a look at the testimonial from our student Dr @oumas….

RT @Collaboratory1: 📣 Webinar recording and slides now available: . "Estimands in Cluster Randomized Trials: Choosing Analyses That Answer….

RT @MRCCTU: 📰❗New paper in #ClinicalTrials: SPIRIT guidelines recommend trial protocols include information on monitoring, but less than ha….

RT @MRCCTU: We’re excited to announce the launch of the MRCCTU @UCL Capacity Strengthening Hub on @info_TGHN! . In the hub, you’ll find lo….

RT @HakDehbi: First webinar of the year this Friday about the online MSc Statistics for Clinical Trials @ucl starting in Sept 2023. Join….

RT @BabakOskooei: MRC CTU Symposium:.Innovative phase III randomised clinical trial designs that address multiple research questions. To re….

RT @MRCCTU: 3️⃣ Don't forget to pop by the #postersession during the breaks, we will be presenting a bunch of posters!. 🗣️ @AnnabelleSouth….

RT @Suzie_cro: Are randomised trials answering clear & useful questions? We conducted this review of published trials to find out https://t….

RT @ColinBBegg: Valid analysis of a clinical trial is frequently challenged by post-randomization events. Tra My Pham and colleagues addres….

RT @IntJEpidemiol: Estimands in cluster-randomized trials: choosing analyses that answer the right question.https:/….

RT @JamillaHussain1: Want to know how best to reduce, handle and report missing data in clinical trials?.Especially those including people….

By providing examples and rationale for how common intercurrent events could be handled in this context, we hope to stimulate & inform future discussions among TB trials team on how estimands should be defined for their trials.